A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum]
Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Cancer Manag Res. 2023;15:651–666. The authors have advised Table 2 on pages 654-656, is incorrect. The correct Table 2 is as follows. Table 2 Baseline characteristics of patients Page 663, Figure 6 caption, the text “(D) OS of B...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-a-novel-and-validated-inflammation-based-prognosis-score-i-peer-reviewed-fulltext-article-CMAR |
Summary: | Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Cancer Manag Res. 2023;15:651–666.
The authors have advised Table 2 on pages 654-656, is incorrect. The correct Table 2 is as follows.
Table 2 Baseline characteristics of patients
Page 663, Figure 6 caption, the text “(D) OS of BCL2 ≥50%; (E) OS of MYC ≥40%” should read “(D) OS of MYC ≥40%; (E) OS of BCL2 ≥50%”.
The authors apologize for these errors and advise they do not affect the results of the paper. |
---|---|
ISSN: | 1179-1322 |